Literature DB >> 24692182

Cultural aspects of healthy BRCA carriers from two ethnocultural groups.

Alicia Navarro de Souza1, Danielle Groleau, Carmen G Loiselle, William D Foulkes, Nora Wong.   

Abstract

We explored the experiences of Ashkenazi Jewish and French Canadian women and meanings attributed to their hereditary breast and ovarian cancer (HBOC) risk. We purposively sampled 40 BRCA1 or BRCA2 (BRCA) mutation carriers and conducted theoretically driven semistructured interviews. According to content analysis, participants from these two ethnocultural groups held divergent meanings associated with being a BRCA carrier and different views pertaining to the illness experience and risk awareness. All participants identified a genetic basis; however, the French Canadian women also expressed other causes. The French Canadian women reported not knowing other carriers in their social environment, whereas the Ashkenazi Jewish women emphasized a strong sense of community contributing to their ethnic risk awareness. Based on these findings, we suggest that French Canadian women could benefit from greater awareness of the HBOC genetic risk and that health care providers should consider ethnically related and individual-based experiences and meanings during counseling.

Entities:  

Keywords:  cancer, breast; cancer, genetics; content analysis; culture / cultural competence; psychosocial issues; risk

Mesh:

Substances:

Year:  2014        PMID: 24692182     DOI: 10.1177/1049732314528756

Source DB:  PubMed          Journal:  Qual Health Res        ISSN: 1049-7323


  7 in total

1.  Prevalence of two BRCA1 mutations, 5382insC and 300T > G, in ovarian cancer patients from Ukraine.

Authors:  I Gorodetska; S Serga; T Lahuta; L Ostapchenko; S Demydov; N Khranovska; O Skachkova; M Inomistova; O Kolesnik; V Svintsitsky; N Tsip; A Peresunko; N Kmit'; O Manzhura; Z Rossokha; O Popova; H Salomakhina; S Kyriachenko; I Kozeretska
Journal:  Fam Cancer       Date:  2017-10       Impact factor: 2.375

2.  Should I Perform Genetic Testing? A Qualitative Look into the Decision Making Considerations of Religious Israeli Undergraduate Students.

Authors:  Merav Siani; Orit Ben-Zvi Assaraf
Journal:  J Genet Couns       Date:  2016-03-15       Impact factor: 2.537

Review 3.  Psychological Distress, Anxiety, and Depression of Cancer-Affected BRCA1/2 Mutation Carriers: a Systematic Review.

Authors:  Johanna Ringwald; Christina Wochnowski; Kristin Bosse; Katrin Elisabeth Giel; Norbert Schäffeler; Stephan Zipfel; Martin Teufel
Journal:  J Genet Couns       Date:  2016-04-14       Impact factor: 2.537

4.  The frequency of BRCA1 founder mutation c.5266dupC (5382insC) in breast cancer patients from Ukraine.

Authors:  Ielizaveta Gorodetska; Svitlana Serga; Natalia Levkovich; Tetiana Lahuta; Ludmila Ostapchenko; Serhyi Demydov; Nikolay Anikusko; Valeriy Cheshuk; Ivan Smolanka; Svitlana Sklyar; Serhyi Polenkov; Oleksander Boichenko; Iryna Kozeretska
Journal:  Hered Cancer Clin Pract       Date:  2015-10-13       Impact factor: 2.857

5.  Survey on Addressing the Information and Support Needs of Jewish Women at Increased Risk for or Diagnosed with Breast Cancer: The Sharsheret Experience.

Authors:  Kenneth P Tercyak; Elana Silber; Andrea C Johnson; Adina Fleischmann; Sarah E Murphy; Darren Mays; Suzanne C O'Neill; Christina M Sharkey; Rochelle Shoretz
Journal:  Healthcare (Basel)       Date:  2015-05-22

6.  Prospective Validation of the Decalogue, a Set of Doctor-Patient Communication Recommendations to Improve Patient Illness Experience and Mood States within a Hospital Cardiologic Ambulatory Setting.

Authors:  Piercarlo Ballo; Massimo Milli; Carly Slater; Fabrizio Bandini; Federico Trentanove; Giulia Comper; Alfredo Zuppiroli; Stefania Polvani
Journal:  Biomed Res Int       Date:  2017-11-21       Impact factor: 3.411

7.  A qualitative reflexive thematic analysis into the experiences of being identified with a BRCA1/2 gene alteration: "So many little, little traumas could have been avoided".

Authors:  Nikolett Zsuzsanna Warner; AnnMarie Groarke
Journal:  BMC Health Serv Res       Date:  2022-08-06       Impact factor: 2.908

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.